Jennifer Mitchell

Data updated

Papers

7 publications

Trials

0 clinical trials

Links

Website

Research Footprint

Jennifer Mitchell appears in 7 tracked papers (2020–2026), most studied alongside MDMA, Psilocybin and Placebo, across Depressive Disorders, PTSD and Substance Use Disorders (SUD).

Most-cited paper: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (942 citations).

Frequent co-authors: Rick Doblin, Berra Yazar-Klosinski and Christopher Nicholas.

7

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

21 collaborators· click a node to visit their profile

Full network →

Compounds

MDMAPsilocybinPlacebo

Topics

Depressive DisordersPTSDSubstance Use Disorders (SUD)Safety & Risk ManagementAlcohol Use Disorder (AUD)SuicidalityPublic Health, Prevention & Behaviour ChangeAnxiety DisordersPalliative & End-of-Life DistressAdolescentsMajor Depressive Disorder (MDD)Interpersonal Functioning & Social Connectedness

Top Collaborators

Affiliations

Institutions, companies, and organisations Jennifer Mitchell is associated with.

University of California, San Francisco

academic

University of California, San Francisco (UCSF) hosts major psychedelic research activity through the Translational Psychedelic Research Program (TrPR), Neuroscape Psychedelics Division, and psychiatry-led clinical research on psychedelic-assisted therapies.

View stakeholder →